Abobotulinumtoxina

CHEMBL2108570 Phase 4 Disetujui Unknown

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A purified protein derived from bacteria that temporarily paralyzes targeted muscles by blocking nerve signals that cause muscle contraction. It is used medically to treat conditions involving abnormal muscle stiffness or spasms, such as cervical dystonia and limb spasticity, as well as cosmetically to reduce facial wrinkles. Effects typically last three to four months, after which the treatment can be repeated.

Area Terapeutik

Infectious Disease Pancreatic Cancer Benign Prostatic Hyperplasia Respiratory Disease Pain Management Rheumatoid Arthritis Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Migraine Generalized Anxiety Disorder Gastroesophageal Reflux Disease Inflammatory Bowel Disease Psoriasis Obstetrics & Gynecology Systemic Lupus Erythematosus Multiple Sclerosis Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Stroke Obesity Transplant Medicine Major Depressive Disorder Breast Cancer Atopic Dermatitis Chronic Pain Atrial Fibrillation Cardiovascular Disease Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A purified protein derived from bacteria that temporarily paralyzes targeted muscles by blocking nerve signals that cause muscle contraction. It is used medically to treat conditions involving abnormal muscle stiffness or spasms, such as cervical dystonia and limb spasticity, as well as cosmetically to reduce facial wrinkles. Effects typically last three to four months, after which the treatment can be repeated.

Yes, Abobotulinumtoxina is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2108570. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Mencari informasi yang ramah bagi pasien?

Abobotulinumtoxina di PillFYI

Data Cepat

Tautan Eksternal

ChEMBL CHEMBL2108570

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.